Schizophrenia Trial, Recruiting NCT06599372 Sponsor: Dominique JANUEL Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06599372
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with schizophrenia according to a standard set of medical criteria called DSM-V
  • People who experience auditory hallucinations (hearing voices or sounds) that have not improved after trying two different antipsychotic medications, each given a proper chance to work
  • People who agree to take part and have signed a consent form
  • People who can speak and understand French
  • People who are covered by the French social security system
  • Women who could become pregnant must be using contraception and have a negative pregnancy test at the time of joining

Who may not be able to join:

  • People who have a metal or electronic device inside their skull, uncontrolled epilepsy, or a cochlear implant (hearing implant), as these may be safety concerns with the treatment used in the trial
  • People who have an unstable or uncontrolled medical condition
  • Women who are pregnant and not using effective contraception
  • People who are currently taking part in another research study, or who have finished one less than one month ago
  • People who are under a legal protection measure known as "safeguard of justice" in France
  • Adults who are under a legal arrangement called curatorship (a form of supervised legal decision-making)
  • People who are minors (under 18) with mental health problems
  • Women who are pregnant or breastfeeding
  • People in vulnerable social situations, including those whose freedom is restricted by a legal or administrative decision, or people who are currently hospitalised
  • People who are not able to give their own informed consent to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dominique JANUEL, Clinical research unit, EPS Ville Evrard

Phone: +33 1 43 09 32 32

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Dominique JANUEL
Registry
ClinicalTrials.gov
Start date
11 July 2022
Est. completion
1 July 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

The evolution will be evaluated mainly with the AHRS (Auditory Hallucinations Rating Scale)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov